Regulation of murine cardiac function by phosphodiesterases type 3 and 4

Current Opinion in Pharmacology

Volumn 11, Issue 6, 2011, Pages 714-719

  Beca, Sanja ^a,b   Aschars Sobbi, Roozbeh ^a,b   Panama, Brian K ^a,b   Backx, Peter H ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMRINONE; CALCIUM CHANNEL L TYPE; CALCIUM ION; CYCLIC AMP; ENOXIMONE; MILRINONE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IV INHIBITOR;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM TRANSPORT; CARDIOVASCULAR DISEASE; EXCITATION CONTRACTION COUPLING; HEART ATRIUM FIBRILLATION; HEART DEPOLARIZATION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HUMAN; INOTROPISM; LONG TERM CARE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SARCOPLASMIC RETICULUM; SUDDEN DEATH; VASCULAR SMOOTH MUSCLE;

EID: 82255183129     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2011.10.017     Document Type: Review

References (68)

1. D.M. Bers Cardiac excitation-contraction coupling Nature 415 2002 198 205 (Pubitemid 34059525)
2. M. Zaccolo, and M.A. Movsesian cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology Circ Res 100 2007 1569 1578 (Pubitemid 46897260)
3. O.E. Osadchii Myocardial phosphodiesterases and regulation of cardiac contractility in health and cardiac disease Cardiovasc Drugs Ther 21 2007 171 194 (Pubitemid 46817476)
4. M.D. Houslay, and D.R. Adams PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization Biochem J 370 2003 1 18 (Pubitemid 36259414)
5. K.L. Dodge-Kafka, L. Langeberg, and J.D. Scott Compartmentation of cyclic nucleotide signaling in the heart: the role of A-kinase anchoring proteins Circ Res 98 2006 993 1001
6. I. Verde, G. Pahlke, M. Salanova, G. Zhang, S. Wang, D. Coletti, J. Onuffer, S.L. Jin, and M. Conti Myomegalin is a novel protein of the golgi/centrosome that interacts with a cyclic nucleotide phosphodiesterase J Biol Chem 276 2001 11189 11198 (Pubitemid 38089303)
7. S.J. Perry, G.S. Baillie, T.A. Kohout, I. McPhee, M.M. Magiera, K.L. Ang, W.E. Miller, A.J. McLean, M. Conti, M.D. Houslay, and R.J. Lefkowitz Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins Science 298 2002 834 836 (Pubitemid 35231537)
8. M. Mongillo, T. McSorley, S. Evellin, A. Sood, V. Lissandron, A. Terrin, E. Huston, A. Hannawacker, M.J. Lohse, and T. Pozzan Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases Circ Res 95 2004 67 75 (Pubitemid 38931837)
9. M. Zaccolo, P. Magalhaes, and T. Pozzan Compartmentalisation of cAMP and Ca(2+) signals Curr Opin Cell Biol 14 2002 160 166
10. M. Georget, P. Mateo, G. Vandecasteele, L. Lipskaia, N. Defer, J. Hanoune, J. Hoerter, C. Lugnier, and R. Fischmeister Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8) FASEB J 17 2003 1380 1391 (Pubitemid 36935653)
11. W. Richter, M. Xie, C. Scheitrum, J. Krall, M.A. Movsesian, and M. Conti Conserved expression and functions of PDE4 in rodent and human heart Basic Res Cardiol 106 2011 249 262
12. Y. Xiang, F. Naro, M. Zoudilova, S.L. Jin, M. Conti, and B. Kobilka Phosphodiesterase 4D is required for beta2 adrenoceptor subtype-specific signaling in cardiac myocytes Proc Natl Acad Sci U S A 102 2005 909 914 (Pubitemid 40282764)
13. 2+ channel current Circ Res 2011
14. 2+ current and protects against ventricular arrhythmias in mice J Clin Invest 121 2011 2651 2661
15. S.E. Lehnart, X.H. Wehrens, S. Reiken, S. Warrier, A.E. Belevych, R.D. Harvey, W. Richter, S.L. Jin, M. Conti, and A.R. Marks Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias Cell 123 2005 25 35 (Pubitemid 41414526)
16. B. Sun, H. Li, Y. Shakur, J. Hensley, S. Hockman, J. Kambayashi, V.C. Manganiello, and Y. Liu Role of phosphodiesterase type 3A and 3B in regulating platelet and cardiac function using subtype-selective knockout mice Cell Signal 19 2007 1765 1771 (Pubitemid 46935432)
17. D.M. Bers Cardiac ryanodine receptor phosphorylation: target sites and functional consequences Biochem J 396 2006 e1 e3
18. C. Franzini-Armstrong, F. Protasi, and V. Ramesh Shape, size, and distribution of Ca(2+) release units and couplons in skeletal and cardiac muscles Biophys J 77 1999 1528 1539
19. L. Li, J. Desantiago, G. Chu, E.G. Kranias, and D.M. Bers Phosphorylation of phospholamban and troponin I in beta-adrenergic-induced acceleration of cardiac relaxation Am J Physiol Heart Circ Physiol 278 2000 H769 H779
20. 2+ transport Circ Res 93 2003 487 490 (Pubitemid 37163227)
21. J.D. Scott, and L.F. Santana A-kinase anchoring proteins: getting to the heart of the matter Circulation 121 2010 1264 1271
22. F. Rochais, A. Abi-Gerges, K. Horner, F. Lefebvre, D.M. Cooper, M. Conti, R. Fischmeister, and G. Vandecasteele A specific pattern of phosphodiesterases controls the cAMP signals generated by different Gs-coupled receptors in adult rat ventricular myocytes Circ Res 98 2006 1081 1088
23. Y. Xiang, and B.K. Kobilka Myocyte adrenoceptor signaling pathways Science 300 2003 1530 1532 (Pubitemid 36682874)
24. V. De Archangelis, R. Liu, D. Soto, and Y. Xiang Differential binding of phosphodiesterase 4D isoforms to {beta}2 adrenoceptor in cardiac myocytes J Biol Chem 2009
25. W. Richter, P. Day, R. Agrawal, M.D. Bruss, S. Granier, Y.L. Wang, S.G. Rasmussen, K. Horner, P. Wang, and T. Lei Signaling from beta1- and beta2-adrenergic receptors is defined by differential interactions with PDE4 EMBO J 27 2008 384 393 (Pubitemid 351161657)
26. T. Christ, A. Engel, U. Ravens, and A.J. Kaumann Cilostamide potentiates more the positive inotropic effects of (-)-adrenaline through beta(2)-adrenoceptors than the effects of (-)-noradrenaline through beta (1)-adrenoceptors in human atrial myocardium Naunyn Schmiedebergs Arch Pharmacol 374 2006 249 253 (Pubitemid 44819257)
27. A. Kaumann, S. Bartel, P. Molenaar, L. Sanders, K. Burrell, D. Vetter, P. Hempel, P. Karczewski, and E.G. Krause Activation of beta2-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C-protein in ventricular myocardium from patients with terminal heart failure Circulation 99 1999 65 72 (Pubitemid 29035959)
28. A. Kaumann, A.B. Semmler, and P. Molenaar The effects of both noradrenaline and CGP12177, mediated through human beta1-adrenoceptors, are reduced by PDE3 in human atrium but PDE4 in CHO cells Naunyn Schmiedebergs Arch Pharmacol 375 2007 123 131 (Pubitemid 46425345)
29. E. Degerman, P. Belfrage, and V.C. Manganiello Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3) J Biol Chem 272 1997 6823 6826 (Pubitemid 27166373)
30. J. Wechsler, Y.H. Choi, J. Krall, F. Ahmad, V.C. Manganiello, and M.A. Movsesian Isoforms of cyclic nucleotide phosphodiesterase PDE3A in cardiac myocytes J Biol Chem 277 2002 38072 38078 (Pubitemid 35154659)
31. D.H. Maurice, D. Palmer, D.G. Tilley, H.A. Dunkerley, S.J. Netherton, D.R. Raymond, H.S. Elbatarny, and S.L. Jimmo Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system Mol Pharmacol 64 2003 533 546 (Pubitemid 37048555)
32. J.P. Morgan, J.K. Gwathmey, T.T. DeFeo, and K.G. Morgan The effects of amrinone and related drugs on intracellular calcium in isolated mammalian cardiac and vascular smooth muscle Circulation 73 1986 III65 III77
33. D.G. Tilley, and D.H. Maurice Vascular smooth muscle cell phosphodiesterase (PDE) 3 and PDE4 activities and levels are regulated by cyclic AMP in vivo Mol Pharmacol 62 2002 497 506 (Pubitemid 36329367)
34. Y. Shakur, L.S. Holst, T.R. Landstrom, M. Movsesian, E. Degerman, and V. Manganiello Regulation and function of the cyclic nucleotide phosphodiesterase (PDE3) gene family Prog Nucleic Acid Res Mol Biol 66 2001 241 277
35. E. Patrucco, A. Notte, L. Barberis, G. Selvetella, A. Maffei, M. Brancaccio, S. Marengo, G. Russo, O. Azzolino, and S.D. Rybalkin PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects Cell 118 2004 375 387 (Pubitemid 39061117)
36. E. Amsellem, C. Kasparien, G. Haddour, J.P. Boissel, and P. Nony Phosphodiesterase iii inhibitors for heart failure Cochr Database Syst Rev (Online) 2005 CD002230
37. M. Packer, J.R. Carver, R.J. Rodeheffer, R.J. Ivanhoe, R. DiBianco, S.M. Zeldis, G.H. Hendrix, W.J. Bommer, U. Elkayam, and M.L. Kukin Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group N Engl J Med 325 1991 1468 1475
38. 2+ current and developed tension in guinea-pig ventricular myocytes and papillary muscle: comparison with IBMX, milrinone, and cilostazol Cardiovasc Drugs Ther 13 1999 105 113 (Pubitemid 29224835)
39. C.O. Malecot, D.M. Bers, and B.G. Katzung Biphasic contractions induced by milrinone at low temperature in ferret ventricular muscle: role of the sarcoplasmic reticulum and transmembrane calcium influx Circ Res 59 1986 151 162 (Pubitemid 16017870)
40. C.O. Malecot, P. Arlock, and B.G. Katzung Amrinone effects on electromechanical coupling and depolarization-induced automaticity in ventricular muscle of guinea pigs and ferrets J Pharmacol Exp Ther 232 1985 10 19 (Pubitemid 15193644)
41. M. Endoh, T. Yanagisawa, N. Taira, and J.R. Blinks Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle Circulation 73 1986 III117 III133
42. J. Kambayashi, Y. Liu, B. Sun, Y. Shakur, M. Yoshitake, and F. Czerwiec Cilostazol as a unique antithrombotic agent Curr Pharm Des 9 2003 2289 2302 (Pubitemid 37236353)
43. M. Endoh, and M. Hori Acute heart failure: inotropic agents and their clinical uses Expert Opin Pharmacother 7 2006 2179 2202
44. W.F. Lubbe, T. Podzuweit, and L.H. Opie Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors J Am Coll Cardiol 19 1992 1622 1633
45. F.U. Muller, J. Neumann, and W. Schmitz Transcriptional regulation by cAMP in the heart Mol Cell Biochem 212 2000 11 17
46. S. Masciarelli, K. Horner, C. Liu, S.H. Park, M. Hinckley, S. Hockman, T. Nedachi, C. Jin, M. Conti, and V. Manganiello Cyclic nucleotide phosphodiesterase 3A-deficient mice as a model of female infertility J Clin Invest 114 2004 196 205 (Pubitemid 39071624)
47. Y.H. Choi, S. Park, S. Hockman, E. Zmuda-Trzebiatowska, F. Svennelid, M. Haluzik, O. Gavrilova, F. Ahmad, L. Pepin, and M. Napolitano Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice J Clin Invest 116 2006 3240 3251 (Pubitemid 44878638)
48. M.L. Reeves, B.K. Leigh, and P.J. England The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors Biochem J 241 1987 535 541 (Pubitemid 17234191)
49. H. von der Leyen, U. Mende, W. Meyer, J. Neumann, M. Nose, W. Schmitz, H. Scholz, J. Starbatty, B. Stein, and Wenzlaff H Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations Naunyn Schmiedebergs Arch Pharmacol 344 1991 90 100
50. T. Bethke, A. Klimkiewicz, C. Kohl, L.H. von der, H. Mehl, U. Mende, W. Meyer, J. Neumann, W. Schmitz, and H. Scholz Effects of isomazole on force of contraction and phosphodiesterase isoenzymes I-IV in nonfailing and failing human hearts J Cardiovasc Pharmacol 18 1991 386 397
51. B.G. Kerfant, D. Zhao, I. Lorenzen-Schmidt, L.S. Wilson, S. Cai, S.R. Chen, D.H. Maurice, and P.H. Backx PI3Kgamma is required for PDE4, not PDE3, activity in subcellular microdomains containing the sarcoplasmic reticular calcium ATPase in cardiomyocytes Circ Res 101 2007 400 408 (Pubitemid 47267708)
52. C. Yan, C.L. Miller, and J. Abe Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart Circ Res 100 2007 489 501 (Pubitemid 46673258)
53. B. Ding, J. Abe, H. Wei, Q. Huang, R.A. Walsh, C.A. Molina, A. Zhao, J. Sadoshima, B.C. Blaxall, B.C. Berk, and C. Yan Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure Circulation 111 2005 2469 2476 (Pubitemid 40696135)
54. A. Abi-Gerges, W. Richter, F. Lefebvre, P. Mateo, A. Varin, C. Heymes, J.L. Samuel, C. Lugnier, M. Conti, R. Fischmeister, and G. Vandecasteele Decreased expression and activity of cAMP phosphodiesterases in cardiac hypertrophy and its impact on beta-adrenergic cAMP signals Circ Res 105 2009 784 792
55. D. Guo, Z. Kassiri, R. Basu, F.L. Chow, V. Kandalam, F. Damilano, W. Liang, S. Izumo, E. Hirsch, and J.M. Penninger Loss of PI3Kgamma enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress Circ Res 107 2010 1275 1289
56. M.K. Rutter, H. Parise, E.J. Benjamin, D. Levy, M.G. Larson, J.B. Meigs, R.W. Nesto, P.W. Wilson, and R.S. Vasan Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study Circulation 107 2003 448 454 (Pubitemid 36158048)
57. M.M. Kostic, S. Erdogan, G. Rena, G. Borchert, B. Hoch, S. Bartel, G. Scotland, E. Huston, M.D. Houslay, and E.G. Krause Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin- preconditioned rat heart J Mol Cell Cardiol 29 1997 3135 3146 (Pubitemid 27510779)
58. M.D. Houslay Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown Trends Biochem Sci 35 2010 91 100
59. A. Galindo-Tovar, and A.J. Kaumann Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors Br J Pharmacol 153 2008 710 720 (Pubitemid 351271768)
60. V. De Archangelis, D. Soto, and Y. Xiang Phosphodiesterase 4 and phosphatase 2A differentially regulate cAMP/protein kinase a signaling for cardiac myocyte contraction under stimulation of beta1 adrenergic receptor Mol Pharmacol 74 2008 1453 1462
61. C.A. Muller, M.G. Worthington, and F.T. Thandroyen Antiarrhythmic and metabolic effects of indoramin during acute regional ischemia and reperfusion in isolated rat heart J Cardiovasc Pharmacol 15 1990 408 413 (Pubitemid 20063741)
62. W.A. Herzer, N.J. Thomas, J.A. Carcillo, S.P. Tofovic, and E.K. Jackson Effects of type IV phosphodiesterase inhibition on cardiac function in the presence and absence of catecholamines J Cardiovasc Pharmacol 32 1998 769 776 (Pubitemid 28506648)
63. T. Ukita, M. Sugahara, Y. Terakawa, T. Kuroda, K. Wada, A. Nakata, Y. Ohmachi, H. Kikkawa, K. Ikezawa, and K. Naito Novel, potent, and selective phosphodiesterase-4 inhibitors as antiasthmatic agents: synthesis and biological activities of a series of 1-pyridylnaphthalene derivatives J Med Chem 42 1999 1088 1099 (Pubitemid 29153437)
64. C. Mehats, S.L. Jin, J. Wahlstrom, E. Law, D.T. Umetsu, and M. Conti PDE4D plays a critical role in the control of airway smooth muscle contraction FASEB J 17 2003 1831 1841 (Pubitemid 37214777)
65. G. Hansen, S. Jin, D.T. Umetsu, and M. Conti Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D Proc Natl Acad Sci U S A 97 2000 6751 6756 (Pubitemid 30412786)
66. W. Richter, S.L. Jin, and M. Conti Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are differentially expressed and regulated in rat tissue Biochem J 388 2005 803 811 (Pubitemid 40941566)
67. P.M. Calverley, K.F. Rabe, U.M. Goehring, S. Kristiansen, L.M. Fabbri, and F.J. Martinez Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials Lancet 374 2009 685 694
68. S.M. Pogwizd, and D.M. Bers Cellular basis of triggered arrhythmias in heart failure Trends Cardiovasc Med 14 2004 61 66 (Pubitemid 38340848)